scispace - formally typeset
Open AccessJournal ArticleDOI

Responses and adverse effects of carboplatin-based chemotherapy for pediatric intracranial germ cell tumors.

TLDR
The current carboplatin-based chemotherapy protocol is safe and effective for the treatment of pediatric patients with IC-GCTs and it is concluded that no lethal hematological complications were associated with this treatment.
Abstract
Purpose Cisplatin-based chemotherapy has been commonly used for the treatment of intracranial germ cell tumors (IC-GCTs). However, this treatment exhibits some adverse effects such as renal problems and hearing difficulty. Carboplatin-based chemotherapy was administered to pediatric patients with IC-GCTs from August 2004 at the Samsung Medical Center. In this study, we assessed the responses and adverse effects of carboplatin-based chemotherapy in pediatric IC-GCTs patients according to the risk group, and compared the results with those of the previous cisplatin-based chemotherapy.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy

TL;DR: Recent advances in Pt (IV) complexes in combination with nanocarriers are highlighted, addressing the shortcomings of Pt ( IV) complexes, such as their instability in blood and irreversibly binding to plasma proteins and nonspecific distribution, and taking advantage of passive and active targeting effect to improve Pt (II) anticancer therapy.
Journal ArticleDOI

Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding Study of Platinum Originating from Dicycloplatin, a Novel Antitumor Supramolecule, in Rats and Dogs by ICP-MS

TL;DR: Investigating the pharmacokinetic characteristics including plasma kinetics, tissue distribution, and plasma protein binding of platinum originating from dicycloplatin in rats and dogs in detail for the first time by ICP-MS showed that plasma concentrations of platinum began to decrease rapidly initially but decline slowly with a long terminal phase.
Journal ArticleDOI

Medulloblastoma/Primitive neuroectodermal tumor and germ cell tumors: the uncommon but potentially curable primary brain tumors.

TL;DR: An overview of medulloblastomas, central nervous system primitive neuroectodermal tumors, and germ cell tumors for the practicing oncologist is presented.
Journal ArticleDOI

Carboplatin-based regimen in pediatric intracranial germ-cell tumors (IC-GCTs): effectiveness and ototoxicity.

TL;DR: Induction chemotherapy with carboplatin-based regimens was associated with excellent survival rates and low ototoxicity in patients with IC-GCT, and Radiotherapy should be given to all patients with a minimal volume equivalent to whole-ventricular radiotherapy, during which doses of lower than 40 Gy can be effectively used.
References
More filters
Journal ArticleDOI

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

TL;DR: Recent progress in the evolution of adverse effects grading systems is updated and the development of CTCAE v3.0 is reviewed, which represents an international collaboration and consensus of the oncology research community.
Journal ArticleDOI

Intracranial germ-cell tumors: natural history and pathogenesis.

TL;DR: The pathogenesis of GCT's may be revealed by their specificity of origin within the positive (suprasellar cistern-suprachiasmatic nucleus) and negative (pineal) regulatory centers for gonadotropin secretion within the diencephalon.
Journal ArticleDOI

Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin

TL;DR: Carboplatin does not possess equivalent activity to cisplatin in all platinum-sensitive tumors, and its role in limited-stage small-cell lung cancer needs to be investigated further.
Journal ArticleDOI

Toxicity of platinum compounds

TL;DR: Compared to cisplatin, carboplatin has inferior efficacy in germ-cell tumour, head and neck cancer and bladder and oesophageal carcinoma, whereas both drugs seem to have comparable efficacy in advanced non-small cell and small cell lung cancer as well as ovarian cancer.
Journal ArticleDOI

Intracranial Germ Cell Tumors

TL;DR: Germinomas have a good prognosis, as over 90% of patients can be effectively treated with radiation therapy, and recent reports suggest that the dose and volume of radiation therapy required for disease control can be lessened with the addition of adjuvant chemotherapy.